Report Detail
Global Parkinson's Disease (PD) Drugs Market Professional Survey Report 2019
- RnM3733085 |
- 07 September, 2019 |
- Global |
- 117 Pages |
- QYResearch |
- Pharma & Healthcare
Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by damage to the dopaminergic neurons located in various parts of the brain, including the substantia nigra.
The emergence of gene therapy to reverse the progression of PD is one of the key trends that will gain traction in the market for parkinsons drugs throughout the estimated period.
The global Parkinson's Disease (PD) Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Parkinson's Disease (PD) Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Parkinson's Disease (PD) Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Parkinson's Disease (PD) Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Parkinson's Disease (PD) Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Boehringer Ingelheim
GlaxoSmithKline
Novartis
Teva Pharmaceutical Industries
AbbVie
Abital Pharma
Addex Therapeutics
Biogen
Eisai
Eli Lilly
F. Hoffmann-La Roche
H. Lundbeck
Impax Laboratories
Kyowa Hakko Kirin
Otsuka Pharmaceutical
Pfizer
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Dopamine Agonist
Monoamine Oxidase Inhibitors
Acetylcholinesterase Inhibitors
Glutamate Inhibitors
Segment by Application
Hospital
Family
Table of Contents
Executive Summary
1 Industry Overview of Parkinson's Disease (PD) Drugs
- 1.1 Definition of Parkinson's Disease (PD) Drugs
- 1.2 Parkinson's Disease (PD) Drugs Segment by Type
- 1.2.1 Global Parkinson's Disease (PD) Drugs Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Dopamine Agonist
- 1.2.3 Monoamine Oxidase Inhibitors
- 1.2.4 Acetylcholinesterase Inhibitors
- 1.2.5 Glutamate Inhibitors
- 1.3 Parkinson's Disease (PD) Drugs Segment by Applications
- 1.3.1 Global Parkinson's Disease (PD) Drugs Consumption Comparison by Applications (2014-2025)
- 1.3.2 Hospital
- 1.3.3 Family
- 1.4 Global Parkinson's Disease (PD) Drugs Overall Market
- 1.4.1 Global Parkinson's Disease (PD) Drugs Revenue (2014-2025)
- 1.4.2 Global Parkinson's Disease (PD) Drugs Production (2014-2025)
- 1.4.3 North America Parkinson's Disease (PD) Drugs Status and Prospect (2014-2025)
- 1.4.4 Europe Parkinson's Disease (PD) Drugs Status and Prospect (2014-2025)
- 1.4.5 China Parkinson's Disease (PD) Drugs Status and Prospect (2014-2025)
- 1.4.6 Japan Parkinson's Disease (PD) Drugs Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Parkinson's Disease (PD) Drugs Status and Prospect (2014-2025)
- 1.4.8 India Parkinson's Disease (PD) Drugs Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Parkinson's Disease (PD) Drugs
- 2.3 Manufacturing Process Analysis of Parkinson's Disease (PD) Drugs
- 2.4 Industry Chain Structure of Parkinson's Disease (PD) Drugs
3 Development and Manufacturing Plants Analysis of Parkinson's Disease (PD) Drugs
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Parkinson's Disease (PD) Drugs Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Parkinson's Disease (PD) Drugs
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Parkinson's Disease (PD) Drugs Production and Capacity Analysis
- 4.2 Parkinson's Disease (PD) Drugs Revenue Analysis
- 4.3 Parkinson's Disease (PD) Drugs Price Analysis
- 4.4 Market Concentration Degree
5 Parkinson's Disease (PD) Drugs Regional Market Analysis
- 5.1 Parkinson's Disease (PD) Drugs Production by Regions
- 5.1.1 Global Parkinson's Disease (PD) Drugs Production by Regions
- 5.1.2 Global Parkinson's Disease (PD) Drugs Revenue by Regions
- 5.2 Parkinson's Disease (PD) Drugs Consumption by Regions
- 5.3 North America Parkinson's Disease (PD) Drugs Market Analysis
- 5.3.1 North America Parkinson's Disease (PD) Drugs Production
- 5.3.2 North America Parkinson's Disease (PD) Drugs Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Parkinson's Disease (PD) Drugs Import and Export
- 5.4 Europe Parkinson's Disease (PD) Drugs Market Analysis
- 5.4.1 Europe Parkinson's Disease (PD) Drugs Production
- 5.4.2 Europe Parkinson's Disease (PD) Drugs Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Parkinson's Disease (PD) Drugs Import and Export
- 5.5 China Parkinson's Disease (PD) Drugs Market Analysis
- 5.5.1 China Parkinson's Disease (PD) Drugs Production
- 5.5.2 China Parkinson's Disease (PD) Drugs Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Parkinson's Disease (PD) Drugs Import and Export
- 5.6 Japan Parkinson's Disease (PD) Drugs Market Analysis
- 5.6.1 Japan Parkinson's Disease (PD) Drugs Production
- 5.6.2 Japan Parkinson's Disease (PD) Drugs Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Parkinson's Disease (PD) Drugs Import and Export
- 5.7 Southeast Asia Parkinson's Disease (PD) Drugs Market Analysis
- 5.7.1 Southeast Asia Parkinson's Disease (PD) Drugs Production
- 5.7.2 Southeast Asia Parkinson's Disease (PD) Drugs Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Parkinson's Disease (PD) Drugs Import and Export
- 5.8 India Parkinson's Disease (PD) Drugs Market Analysis
- 5.8.1 India Parkinson's Disease (PD) Drugs Production
- 5.8.2 India Parkinson's Disease (PD) Drugs Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Parkinson's Disease (PD) Drugs Import and Export
6 Parkinson's Disease (PD) Drugs Segment Market Analysis (by Type)
- 6.1 Global Parkinson's Disease (PD) Drugs Production by Type
- 6.2 Global Parkinson's Disease (PD) Drugs Revenue by Type
- 6.3 Parkinson's Disease (PD) Drugs Price by Type
7 Parkinson's Disease (PD) Drugs Segment Market Analysis (by Application)
- 7.1 Global Parkinson's Disease (PD) Drugs Consumption by Application
- 7.2 Global Parkinson's Disease (PD) Drugs Consumption Market Share by Application (2014-2019)
8 Parkinson's Disease (PD) Drugs Major Manufacturers Analysis
- 8.1 Boehringer Ingelheim
- 8.1.1 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Production Sites and Area Served
- 8.1.2 Boehringer Ingelheim Product Introduction, Application and Specification
- 8.1.3 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 GlaxoSmithKline
- 8.2.1 GlaxoSmithKline Parkinson's Disease (PD) Drugs Production Sites and Area Served
- 8.2.2 GlaxoSmithKline Product Introduction, Application and Specification
- 8.2.3 GlaxoSmithKline Parkinson's Disease (PD) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Novartis
- 8.3.1 Novartis Parkinson's Disease (PD) Drugs Production Sites and Area Served
- 8.3.2 Novartis Product Introduction, Application and Specification
- 8.3.3 Novartis Parkinson's Disease (PD) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Teva Pharmaceutical Industries
- 8.4.1 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Production Sites and Area Served
- 8.4.2 Teva Pharmaceutical Industries Product Introduction, Application and Specification
- 8.4.3 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 AbbVie
- 8.5.1 AbbVie Parkinson's Disease (PD) Drugs Production Sites and Area Served
- 8.5.2 AbbVie Product Introduction, Application and Specification
- 8.5.3 AbbVie Parkinson's Disease (PD) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Abital Pharma
- 8.6.1 Abital Pharma Parkinson's Disease (PD) Drugs Production Sites and Area Served
- 8.6.2 Abital Pharma Product Introduction, Application and Specification
- 8.6.3 Abital Pharma Parkinson's Disease (PD) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 Addex Therapeutics
- 8.7.1 Addex Therapeutics Parkinson's Disease (PD) Drugs Production Sites and Area Served
- 8.7.2 Addex Therapeutics Product Introduction, Application and Specification
- 8.7.3 Addex Therapeutics Parkinson's Disease (PD) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Biogen
- 8.8.1 Biogen Parkinson's Disease (PD) Drugs Production Sites and Area Served
- 8.8.2 Biogen Product Introduction, Application and Specification
- 8.8.3 Biogen Parkinson's Disease (PD) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 Eisai
- 8.9.1 Eisai Parkinson's Disease (PD) Drugs Production Sites and Area Served
- 8.9.2 Eisai Product Introduction, Application and Specification
- 8.9.3 Eisai Parkinson's Disease (PD) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
- 8.10 Eli Lilly
- 8.10.1 Eli Lilly Parkinson's Disease (PD) Drugs Production Sites and Area Served
- 8.10.2 Eli Lilly Product Introduction, Application and Specification
- 8.10.3 Eli Lilly Parkinson's Disease (PD) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.10.4 Main Business and Markets Served
- 8.11 F. Hoffmann-La Roche
- 8.12 H. Lundbeck
- 8.13 Impax Laboratories
- 8.14 Kyowa Hakko Kirin
- 8.15 Otsuka Pharmaceutical
- 8.16 Pfizer
9 Development Trend of Analysis of Parkinson's Disease (PD) Drugs Market
- 9.1 Global Parkinson's Disease (PD) Drugs Market Trend Analysis
- 9.1.1 Global Parkinson's Disease (PD) Drugs Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Parkinson's Disease (PD) Drugs Regional Market Trend
- 9.2.1 North America Parkinson's Disease (PD) Drugs Forecast 2019-2025
- 9.2.2 Europe Parkinson's Disease (PD) Drugs Forecast 2019-2025
- 9.2.3 China Parkinson's Disease (PD) Drugs Forecast 2019-2025
- 9.2.4 Japan Parkinson's Disease (PD) Drugs Forecast 2019-2025
- 9.2.5 Southeast Asia Parkinson's Disease (PD) Drugs Forecast 2019-2025
- 9.2.6 India Parkinson's Disease (PD) Drugs Forecast 2019-2025
- 9.3 Parkinson's Disease (PD) Drugs Market Trend (Product Type)
- 9.4 Parkinson's Disease (PD) Drugs Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Parkinson's Disease (PD) Drugs Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Parkinson's Disease (PD) Drugs. Industry analysis & Market Report on Parkinson's Disease (PD) Drugs is a syndicated market report, published as Global Parkinson's Disease (PD) Drugs Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Parkinson's Disease (PD) Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
